Podcast: Download (Duration: 1:04 — 1.5MB)
Subscribe: RSS
The FDA has just approved a drug called omalizumab used to treat asthma to treat multiple, severe food allergy. Robert Wood, an allergy expert at Johns Hopkins and principal investigator on the study that demonstrated the drug’s efficacy, says the …
Podcast: Download (Duration: 1:02 — 1.4MB)
Subscribe: RSS
A drug called omalizumab has just been approved to treat severe food allergies. Robert Wood, Johns Hopkins allergy expert and principal investigator on a study proving the efficacy of this drug, says it’s needed because the strategy of feeding increasing …
Podcast: Download (Duration: 1:05 — 1.5MB)
Subscribe: RSS
Myc, ras, BRCA…these are all shorthand for common cancer mutations, with a new study saying that’s how cancers should be identified rather than which organ or system they’re found in, since not knowing the mutations may delay proper treatment. Kimmel …
Podcast: Download (Duration: 1:04 — 1.5MB)
Subscribe: RSS
All cancers carry mutations, and these should direct how they are named, NOT where they are located. That’s the stance of a new study finding that treatments that are targeted to the actual mutations a cancer carries rely on identifying …
Should cancers be named differently? Elizabeth Tracey reports Read more »
Podcast: Download (Duration: 1:03 — 1.4MB)
Subscribe: RSS
While overall cancer deaths are continuing their decline, there are three that are still problematic, the most recent data from the American Cancer Society demonstrates. Johns Hopkins Kimmel Cancer Center director William Nelson names them. Nelson: The ones to watch …
Deaths from certain cancers continue to rise, Elizabeth Tracey reports Read more »
